539 related articles for article (PubMed ID: 29473979)
1. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.
Li T; Jiao JJ; Hölscher C; Wu MN; Zhang J; Tong JQ; Dong XF; Qu XS; Cao Y; Cai HY; Su Q; Qi JS
Hippocampus; 2018 May; 28(5):358-372. PubMed ID: 29473979
[TBL] [Abstract][Full Text] [Related]
2. [GLP-1/GIP/Gcg receptor Triagonist improves the cognitive behaviors in triple-transgenic mice of Alzheimer's disease].
Jiao JJ; Hölscher C; Li T; Dong XF; Qu XS; Cao Y; Wu MN; Wang ZJ; Qi JS
Sheng Li Xue Bao; 2017 Apr; 69(2):135-145. PubMed ID: 28435972
[TBL] [Abstract][Full Text] [Related]
3. A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca
Li T; Jiao JJ; Su Q; Hölscher C; Zhang J; Yan XD; Zhao HM; Cai HY; Qi JS
Neuropharmacology; 2020 Jun; 170():108042. PubMed ID: 32147454
[TBL] [Abstract][Full Text] [Related]
4. DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
Cao Y; Hölscher C; Hu MM; Wang T; Zhao F; Bai Y; Zhang J; Wu MN; Qi JS
Eur J Pharmacol; 2018 May; 827():215-226. PubMed ID: 29551659
[TBL] [Abstract][Full Text] [Related]
5. A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice.
Wang ZJ; Han YF; Zhao F; Yang GZ; Yuan L; Cai HY; Yang JT; Holscher C; Qi JS; Wu MN
Horm Behav; 2020 Feb; 118():104640. PubMed ID: 31765661
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.
Tai J; Liu W; Li Y; Li L; Hölscher C
Brain Res; 2018 Jan; 1678():64-74. PubMed ID: 29050859
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
Yan XD; Qu XS; Yin J; Qiao J; Zhang J; Qi JS; Wu MN
J Alzheimers Dis; 2022; 85(1):343-357. PubMed ID: 34806605
[TBL] [Abstract][Full Text] [Related]
8. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
Shi L; Zhang Z; Li L; Hölscher C
Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
[TBL] [Abstract][Full Text] [Related]
9. A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
Cai HY; Yang D; Qiao J; Yang JT; Wang ZJ; Wu MN; Qi JS; Hölscher C
J Alzheimers Dis; 2021; 83(2):799-818. PubMed ID: 34366339
[TBL] [Abstract][Full Text] [Related]
10. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury.
Li Y; Glotfelty EJ; Namdar I; Tweedie D; Olson L; Hoffer BJ; DiMarchi RD; Pick CG; Greig NH
Exp Neurol; 2020 Feb; 324():113113. PubMed ID: 31730763
[TBL] [Abstract][Full Text] [Related]
12. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
Kosaraju J; Holsinger RMD; Guo L; Tam KY
Mol Neurobiol; 2017 Oct; 54(8):6074-6084. PubMed ID: 27699599
[TBL] [Abstract][Full Text] [Related]
13. DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
Yuan L; Zhang J; Guo JH; Holscher C; Yang JT; Wu MN; Wang ZJ; Cai HY; Han LN; Shi H; Han YF; Qi JS
J Alzheimers Dis; 2021; 80(2):695-713. PubMed ID: 33579843
[TBL] [Abstract][Full Text] [Related]
14. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
[TBL] [Abstract][Full Text] [Related]
15. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
17. The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.
Li C; Liu W; Li X; Zhang Z; Qi H; Liu S; Yan N; Xing Y; Hölscher C; Wang Z
Brain Behav; 2020 Mar; 10(3):e01505. PubMed ID: 31960630
[TBL] [Abstract][Full Text] [Related]
18. Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist.
Bossart M; Wagner M; Elvert R; Evers A; Hübschle T; Kloeckener T; Lorenz K; Moessinger C; Eriksson O; Velikyan I; Pierrou S; Johansson L; Dietert G; Dietz-Baum Y; Kissner T; Nowotny I; Einig C; Jan C; Rharbaoui F; Gassenhuber J; Prochnow HP; Agueusop I; Porksen N; Smith WB; Nitsche A; Konkar A
Cell Metab; 2022 Jan; 34(1):59-74.e10. PubMed ID: 34932984
[TBL] [Abstract][Full Text] [Related]
19. Rational design of a GLP-1/GIP/Gcg receptor triagonist to correct hyperglycemia, obesity and diabetic nephropathy in rodent animals.
Cui J; Shang A; Wang W; Chen W
Life Sci; 2020 Nov; 260():118339. PubMed ID: 32841660
[TBL] [Abstract][Full Text] [Related]
20. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.
Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS
Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
